Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics

White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications

White, T. C., Bruns, T. D., Lee, S., Taylor, F. J. R., White, T., Lee, S., Taylor, D. L., & Shawe‐Taylor, J. (1990) · Cited by 2,604 · see citing works

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · see citing works

PCR Protocols-A Guide to Methods and Applications

Gurr, S. J. (1991) · Biochemical Education · doi:10.1016/0307-4412(91)90165-5 · Cited by 1,168 · see citing works

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Cornely, O. A., Arıkan-Akdağlı, S., Dannaoui, É., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 864 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

Global trends in the distribution of Candida species causing candidemia

Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680 · see citing works

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656 · see citing works

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

Rodríguez-Tudela, J. L., Arendrup, M. C., Barchiesi, F., Billé, J., Chryssanthou, E., Cuenca‐Estrella, M., Dannaoui, É., Denning, D. W., Donnelly, J. P., Dromer, F., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01935.x · Cited by 651 · see citing works

Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and III

Tavanti, A., Davidson, A. D., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.284-292.2005 · Cited by 593 · see citing works

Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

Almirante, B., Rodríguez-Pardo, D., Park, B. J., Cuenca‐Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sánchez, F., Ayats, J., Giménez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 567 · see citing works

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03880.x · Cited by 451 · see citing works

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362 · see citing works

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods

Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314 · see citing works

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain

Puig‐Asensio, M., Padilla, B., Garnacho‐Montero, J., Zaragoza, Ó., Aguado, J. M., Zaragoza, R., Montejo, M., Muñóz, P., Ruíz-Camps, I., Cuenca‐Estrella, M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12380 · Cited by 297 · see citing works

Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints

Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · see citing works

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Pfaller, M. A., Messer, S. A., Woosley, L. N., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00308-13 · Cited by 237 · see citing works

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01398-10 · Cited by 228 · see citing works

National Surveillance of Fungemia in Denmark (2004 to 2009)

Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-10 · Cited by 223 · see citing works

Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: Should the clinical laboratory be testing this agent?

Espinel-Ingroff, A., Arendrup, M. C., Pfaller, M. A., Bonfietti, L. X., Bustamante, B., Canton, E., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Fothergill, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01519-13 · Cited by 216 · see citing works

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

Aller, A. I., Martín‐Mazuelos, E., Lozano, F., Gómez-Mateos, J. M., Steele‐Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F., & Espinel-Ingroff, A. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1544-1548.2000 · Cited by 171 · see citing works

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

Pemán, J., Cantón, R., Quindós, G., Eraso, E., Alcoba-Flórez, J., Guinea, J., Merino, P., Ruiz-Pérez-de-Pipaon, M. T., del Molino, L. P., Linares-Sicilia, M. J., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks019 · Cited by 159 · see citing works

Mutations in the <i>fks1</i> Gene in <i>Candida albicans</i> , <i>C. tropicalis</i> , and <i>C. krusei</i> Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing

Desnos-Ollivier, M., Bretagne, S., Raoux, D., Hoinard, D., Dromer, F., & Dannaoui, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00088-08 · Cited by 132 · see citing works

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129 · see citing works

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Guinea, J., Zaragoza, Ó., Escribano, P., Martín‐Mazuelos, E., Pemán, J., Sánchez, F., & Cuenca‐Estrella, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02155-13 · Cited by 129 · see citing works

Clinical and microbiological aspects of candidemia due toCandida parapsilosisin Brazilian tertiary care hospitals

Brito, L. R., Guimarães, T., Nucci, M., Rosas, R. C., de Almeida, L. P., da Matta, D. A., & Colombo, A. L. (2006) · Medical Mycology · doi:10.1080/13693780500421476 · Cited by 61 · see citing works

Molecular Identification of Closely Related Candida Species Using Two Ribosomal Intergenic Spacer Fingerprinting Methods

Cornet, M., Sendid, B., Fradin, C., Gaillardin, C. M., Poulain, D., & Nguyen, H.-V. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.014 · Cited by 59 · see citing works

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin

Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02120-10 · Cited by 59 · see citing works

Echinocandin Susceptibility Testing of <i>Candida</i> spp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots

Arendrup, M. C., Rodriguez-Tudela, J.-L., Park, S., Garcia-Effron, G., Delmas, G., Cuenca-Estrella, M., Gomez-Lopez, A., & Perlin, D. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01364-10 · Cited by 57 · see citing works

Variación de la epidemiología de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los últimos 10 años en España: resultados del estudio FUNGEMYCA

Pemán, J., Cantón, E., Camarena, J. J., Alcoba-Flórez, J., Echeverría, J., Ortega, D. N., Alarcón, J. M., Fontanals, D., Sard, B. G., Moreno, B. B., et al. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.02.005 · Cited by 36 · see citing works

Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections

Xu, J., Millar, B. C., Moore, J. E., McClurg, R., Walker, M. J., Evans, J., Hedderwick, S., & McMullan, R. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.10.774 · Cited by 31 · see citing works

Molecular Identification of Candida orthopsilosis Isolated from Blood Culture

Yong, P. V. C., Chong, P. P., Lau, L. Y., et al. (2008) · Mycopathologia · doi:10.1007/s11046-007-9086-8 · Cited by 20 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens

Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145 · see citing works

Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and <i>In Vivo</i> Impact in Infected Galleria mellonella Larvae

Souza, A. C. R., Fuchs, B. B., Pinhati, H. M. S., Siqueira, R. A., Hagen, F., Meis, J. F., Mylonakis, E., & Colombo, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-15 · Cited by 121 · see citing works

A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia

Wilson, A. G., Micek, S. T., & Ritchie, D. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.007 · Cited by 16 · see citing works

[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].

Thomas, F., Mebtouche, B., Clavier, H., et al. (2000) · PubMed · Cited by 1 · see citing works

Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis

Huttova, M., HARTMANOVA, I., Králinský, K., FILKA, J., Uher, J., Kurak, J., Krizan, S., & Krcmery, V. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199811000-00010 · Cited by 120 · see citing works

Fluconazole Use as an Important Risk Factor in the Emergence of Fluconazole-Resistant Candida glabrata Fungemia

Tumbarello, M., Posteraro, B., Trecarichi, E. M., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.243 · Cited by 6 · see citing works

Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose

Eschenauer, G. A., Carver, P. L., Patel, T. S., Lin, S., Klinker, K. P., Pai, M. P., & Lam, S. W. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02566-17 · Cited by 16 · see citing works